<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Cardiomyopathies</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

  <h1>Cardiomyopathies</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
          <br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Definition</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Primary myocardial disease</strong>, or <strong>cardiomyopathy</strong>, is a disease of the heart muscle itself, not associated with congenital, valvular, or coronary heart disease or systemic disorders.</li>
              <li>It is distinct from the specific heart muscle diseases of known cause.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Classification</a>
          </h2>
        </header>
        <div class='body'>
          <p><strong>Cardiomyopathy</strong> has been classified into three types based on anatomic and functional features:</p>
          <ul>
              <li><strong>Hypertrophic</strong></li>
              <li><strong>Dilated</strong> (or congestive)</li>
              <li><strong>Restrictive</strong></li>
              <li><strong>Arrhythmogenic right ventricular cardiomyopathy</strong></li>
              <li><strong>Left ventricular noncompaction</strong></li>
          </ul>
          

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Characteristics</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Dilated</strong> (or congestive) cardiomyopathy is characterized by:
                  <ul>
                      <li>Decreased contractile function of the ventricle associated with ventricular dilatation.</li>
                      <li><strong>Diastolic dysfunction</strong> and <strong>systolic dysfunction</strong></li>
                      <li><strong>Endocardial fibroelastosis</strong> (seen in infancy) and <strong>doxorubicin cardiomyopathy</strong> (seen in children who have received chemotherapy for malignancies) have clinical features similar to those of dilated cardiomyopathy.</li>
                  </ul>
              </li>
              <li><strong>HCM</strong>
                  <ul>
                      <li>There is massive ventricular hypertrophy with a smaller than normal ventricular cavity.</li>
                      <li>Contractile function of the ventricle is enhanced, but ventricular filling is impaired by relaxation abnormalities.</li>
                      <li><strong>Diastolic dysfunction</strong></li>
                      <li>Dynamic systolic dysfunction</li>
                  </ul>
              </li>
              <li><strong>RCM</strong>
                  <ul>
                      <li>Denotes a restriction of diastolic filling of the ventricles (usually infiltrative disease).</li>
                      <li>Contractile function of the ventricle may be normal, but there is marked dilatation of both atria.</li>
                  </ul>
              </li>
          </ul>
          
                      <!-- image here -->
                      <div class="image-container">
                        <img src="../figures/" alt="" onclick="openModal(this)">
                        <div class="caption">Cardiomyopathies</div>
                      </div>
                      
                      <div id="myModal" class="modal">
                        <span class="close" onclick="closeModal()">&times;</span>
                        <img class="modal-content" id="modalImage">
                        <div id="caption" class="caption">Cardiomyopathies</div>
                      </div>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>DCM</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Dilated cardiomyopathy</strong> is the most common form of cardiomyopathy.</li>
          </ul>
          
          <h4>Aetiology</h4>
          <ul>
              <li>The most common cause of dilated cardiomyopathy is <strong>idiopathic</strong> (&gt;60%).</li>
              <li><strong>Familial cardiomyopathy</strong>: AD, X-linked, AR, mitochondrial</li>
              <li><strong>Active myocarditis</strong></li>
              <li><strong>Subclinical myocarditis</strong></li>
              <li>Infectious causes other than viral infection (bacterial, fungal, protozoal, rickettsial)</li>
              <li><strong>Endocrine-metabolic disorders</strong> (hyper- and hypothyroidism, excessive catecholamines, diabetes, hypocalcemia, hypophosphatemia, glycogen storage disease, mucopolysaccharidoses)</li>
              <li><strong>Nutritional disorders</strong> (kwashiorkor, beriberi, carnitine deficiency)</li>
              <li>Cardiotoxic agents such as <strong>doxorubicin</strong></li>
              <li>Systemic diseases such as connective tissue disease</li>
          </ul>
          
          <h4>Pathology/Pathophysiology</h4>
          <ul>
              <li>There is a weakening of systolic contraction with associated dilatation of all four cardiac chambers.</li>
              <li>Dilatation of the atria is in proportion to ventricular dilatation.</li>
              <li>The ventricular walls are not thickened, although heart weight is increased.</li>
              <li>Intracavitary thrombus formation is common in the apical portion of the ventricular cavities and in atrial appendages and may give rise to pulmonary and systemic emboli.</li>
              <li>Histologic examinations from endomyocardial biopsies show varying degrees of myocyte hypertrophy and fibrosis. Inflammatory cells are usually absent.</li>
          </ul>
          
          <h4>Clinical Features</h4>
          <ul>
              <li>A history of fatigue, weakness, and symptoms of <strong>left-sided heart failure</strong> (dyspnea on exertion, orthopnea) may be elicited.</li>
              <li>A history of prior viral illness is occasionally obtained.</li>
          </ul>
          
          <h4>Physical Examination</h4>
          <ul>
              <li><strong>Palpitation</strong>, syncope, and sudden death.</li>
              <li>Features of FTT:
                  <ul>
                      <li><strong>Dyspnoea</strong>, easy fatigability, wheezing, cough</li>
                      <li><strong>Pallor</strong></li>
                      <li>Altered consciousness</li>
                      <li><strong>Hypotension</strong></li>
                      <li>Shock</li>
                      <li>Signs of CHF (tachycardia, pulmonary crackles, weak peripheral pulses, distended neck veins, hepatomegaly) are present.</li>
                      <li>The apical impulse is usually displaced to the left and inferiorly.</li>
                      <li>The S2 may be normal or narrowly split with accentuated P2 if pulmonary hypertension develops.</li>
                      <li>A prominent S3 is present with or without gallop rhythm.</li>
                      <li>A soft regurgitant systolic murmur (caused by mitral or tricuspid regurgitation) may be present.</li>
                  </ul>
              </li>
          </ul>
          
          <h4>Investigations</h4>
          <ul>
              <li><strong>ECG</strong>
                  <ul>
                      <li>Sinus tachycardia, LVH, and ST-T changes are the most common findings.</li>
                      <li>Left or right atrial hypertrophy (LAH or RAH) may be present.</li>
                      <li>Atrial or ventricular arrhythmias and atrioventricular (AV) conduction disturbances may be seen.</li>
                  </ul>
              </li>
              <li><strong>Chest X-ray</strong>
                  <ul>
                      <li>Cardiomegaly</li>
                      <li>Pulmonary vascular congestion</li>
                  </ul>
              </li>
              <li><strong>ECHO</strong></li>
              <li><strong>E/U/Cr</strong></li>
              <li><strong>ESR</strong></li>
              <li><strong>FBC</strong></li>
          </ul>
          
          <h4>Treatment</h4>
          <ul>
              <li><strong>Medical treatment</strong>
                  <ul>
                      <li>Is aimed at the underlying heart failure.</li>
                      <li>Diuretics (furosemide, spironolactone)</li>
                      <li>Digoxin, and angiotensin-converting enzyme (ACE) inhibitors (captopril, enalapril) are an integral part of therapy.</li>
                      <li>Bed rest or restriction of activity.</li>
                  </ul>
              </li>
              <li>Critically ill children may require intubation and mechanical ventilation.</li>
              <li>Rapidly acting intravenous inotropic support (dobutamine, dopamine) is often needed.</li>
              <li>Use of Œ≤-adrenergic blocker therapy in children with chronic heart failure has been shown to improve LV ejection fraction. <strong>Carvedilol</strong> is a Œ≤-adrenergic blocker with additional vasodilating action.</li>
              <li>Antiplatelet agents (aspirin) should be initiated. The propensity for thrombus formation in patients with dilated cardiac chambers and blood stasis may prompt use of anticoagulation with warfarin.</li>
              <li>If thrombi are detected, they should be treated aggressively with heparin initially and later switched to long-term warfarin therapy.</li>
              <li>Patients with arrhythmias may be treated with amiodarone or other antiarrhythmic agents.</li>
              <li>For symptomatic bradycardia, a cardiac pacemaker may be necessary.</li>
              <li>If carnitine deficiency is considered as the cause for the cardiomyopathy, carnitine supplementation should be started.</li>
          </ul>
          
          <h4>Prognosis</h4>
          <ul>
              <li>Progressive deterioration is the rule rather than the exception. About two-thirds of patients die from intractable heart failure within 4 years after the onset of symptoms of CHF.</li>
              <li>Systemic and pulmonary embolism resulting from dislodgment of intracavitary thrombi occurs in the late stages of the illness.</li>
              <li>Causes of death are CHF, sudden death resulting from arrhythmias, and massive embolization.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>HCM</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>HCM</strong> is a heterogeneous, usually familial disorder of heart muscle.</li>
          </ul>
          
          <h4>Aetiology</h4>
          <ul>
              <li>In about 50% of cases, HCM is inherited as a Mendelian <strong>autosomal dominant</strong> trait and is caused by mutations in one of 10 genes encoding protein components of the cardiac sarcomere (such as Œ≤-myosin heavy chain, myosin binding protein C, and cardiac troponin-T).</li>
              <li>Other cases are sporadic.</li>
              <li><strong>LEOPARD syndrome</strong></li>
              <li><strong>Infants of diabetic mothers</strong></li>
          </ul>
          
          <h4>Pathology/Pathophysiology</h4>
          <ul>
              <li>The most characteristic abnormality is the hypertrophied left ventricle (LV), with the ventricular cavity usually small or normal in size.</li>
              <li>Although asymmetrical septal hypertrophy, a condition formerly known as idiopathic hypertrophic subaortic stenosis, is most common, the hypertrophy may be concentric or localized to a small segment of the septum.</li>
              <li>Microscopically, an extensive disarray of hypertrophied myocardial cells, myocardial scarring, and abnormalities of the small intramural coronary arteries are present.</li>
          </ul>
          
          <h4>Pathophysiology</h4>
          <ul>
              <li><strong>Subaortic obstruction</strong></li>
              <li><strong>Diastolic dysfunction</strong></li>
              <li><strong>Mitral regurgitation</strong></li>
              <li>Obstruction may vary from moment to moment.</li>
          </ul>
          
          <h4>Clinical Manifestations</h4>
          <ul>
              <li><strong>History</strong>
                  <ul>
                      <li>Easy fatigability, dyspnea, palpitation, dizziness, syncope, or anginal pain may be present.</li>
                      <li>Family history is positive for the disease in 30% to 60% of patients.</li>
                  </ul>
              </li>
              <li><strong>Physical Examination</strong>
                  <ul>
                      <li>A sharp upstroke of the arterial pulse is characteristic (in contrast to a slow upstroke seen with fixed aortic stenosis [AS]).</li>
                      <li>A left ventricular lift and a systolic thrill at the apex or along the lower left sternal border may be present.</li>
                      <li>Hyperactive precordium.</li>
                      <li>The S2 is normal, and an ejection click is generally absent.</li>
                      <li>A grade 1 to 3/6 ejection systolic murmur of medium pitch is most audible at the middle and lower left sternal borders or at the apex.</li>
                      <li>A soft holosystolic murmur of mitral regurgitation (MR) is often present.</li>
                  </ul>
              </li>
          </ul>
          

          <h4>Investigations</h4>
          <ul>
              <li><strong>ECG</strong>
                  <ul>
                      <li>The ECG is abnormal in the majority of patients.</li>
                      <li>Common ECG abnormalities include <strong>left ventricular hypertrophy (LVH)</strong>, ST-T changes, and abnormally deep Q waves (owing to septal hypertrophy) with diminished or absent R waves in the left precordial leads.</li>
                      <li>Occasionally, "giant" negative T waves are seen in the left precordial leads, which may suggest apical HCM.</li>
                      <li>Other ECG abnormalities may include cardiac arrhythmias and first-degree AV block.</li>
                  </ul>
              </li>
              <li><strong>ECHO</strong></li>
              <li><strong>Chest X-ray</strong></li>
              <li><strong>Urinalysis</strong></li>
              <li><strong>Blood culture</strong></li>
              <li><strong>E/U/Cr</strong></li>
          </ul>
          
          <h4>Treatment</h4>
          <ul>
              <li><strong>Medical</strong>
                  <ul>
                      <li>Moderate restriction of physical activity is recommended. Patients with the diagnosis of HCM should avoid strenuous exercise or competitive sports.</li>
                      <li><strong>Digitalis is contraindicated</strong> because it increases the degree of obstruction.</li>
                      <li>Prophylaxis against SBE is indicated.</li>
                      <li>Clinical screening of first-degree relatives and other family members should be encouraged.</li>
                      <li>Annual evaluation during adolescence (12 to 18 years of age) is recommended, with physical examination, ECG, and two-dimensional echo studies.</li>
                  </ul>
              </li>
              <li>A Œ≤-adrenergic blocker (such as propranolol, atenolol, or metoprolol) is the preferred drug for symptomatic patients with outflow gradient, which develops only with exertion. This drug reduces the degree of outflow tract obstruction, decreases the incidence of anginal pain, and has antiarrhythmic effects.</li>
              <li>Calcium channel blockers (principally verapamil) may be equally effective in both the nonobstructive and obstructive forms.</li>
              <li>Disopyramide (negative inotropic agent and type IA antiarrhythmic agent) has been shown to provide symptomatic benefit in patients with resting obstruction.</li>
          </ul>
          
          <h4>Surgical</h4>
          <ul>
              <li>Morrow's myotomy-myectomy. Transaortic LV septal myotomy-myectomy (the Morrow operation) is the procedure of choice for drug-refractory patients with LVOT obstruction.</li>
              <li>Percutaneous alcohol septal ablation.</li>
          </ul>
          
          <h4>Prognosis</h4>
          <ul>
              <li>Death is often sudden and unexpected and typically is associated with sports or vigorous exertion.</li>
              <li>Sudden death may occur most commonly in patients between 10 and 35 years of age.</li>
              <li>Ventricular fibrillation is the cause of death in the majority of sudden deaths.</li>
              <li>Atrial fibrillation may cause stroke or heart failure.</li>
              <li>In a minority of patients, heart failure with cardiac dilatation ("burned out" phase of the disease) may develop later in life.</li>
              <li>Subacute bacterial endocarditis (SBE) may affect the mitral valve, at the point of mitral-septal contact, or the aortic valve.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>RCM</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li>Incidence increases with age</li>
              <li>Storage disorders</li>
              <li>Infiltrative disorders</li>
          </ul>
          
          <h4>Pathology/Pathophysiology</h4>
          <ul>
              <li>Normal ventricular dimensions, myocardial wall thickness</li>
              <li>Preserved systolic function</li>
              <li>The most characteristic abnormality is impaired ventricular compliance and filling, and atrial dilatation</li>
          </ul>
          
          <h4>Pathophysiology</h4>
          <ul>
              <li>Diastolic dysfunction</li>
              <li>Pulmonary hypertension</li>
              <li>PVD</li>
          </ul>
          
          <h4>Clinical Manifestations</h4>
          <ul>
              <li><strong>History</strong>
                  <ul>
                      <li>Cough, dyspnea, pulmonary oedema</li>
                      <li>Dyspnea, palpitation, dizziness, syncope, or anginal pain may be present</li>
                      <li>Sudden death</li>
                  </ul>
              </li>
              <li><strong>Physical Examination</strong>
                  <ul>
                      <li>Murmurs are usually absent</li>
                      <li>Loud P2</li>
                      <li>Gallop rhythm</li>
                      <li>Overactive right ventricular impulse</li>
                  </ul>
              </li>
          </ul>
          
          <h4>Investigations</h4>
          <ul>
              <li><strong>ECG</strong>
                  <ul>
                      <li>Prominent P wave</li>
                      <li>RVH</li>
                  </ul>
              </li>
              <li><strong>CXR</strong></li>
              <li><strong>ECHO</strong></li>
          </ul>
          
          <h4>Management</h4>
          <ul>
              <li>Limited use of drug management</li>
              <li>Cardiac transplantation</li>
              <li>Antiarrhythmic drugs</li>
              <li>Anticoagulants</li>
              <li><strong>Prognosis is poor</strong></li>
          </ul>
          
        </div>
      </section>








      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
